AP
Ananthaneni Pavana Sudha
About Ananthaneni Pavana Sudha
Data last updated:
Ananthaneni Pavana Sudha is a Director at Rbc Pharmaceuticals Private Limited (since 2023). The company operates in Paper. Rbc Pharmaceuticals Private Limited reported revenue of ₹54.1 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Rbc Pharmaceuticals Private Limited U21001AP2023PTC111221 | Director | 25 May 2023 | 2023 | ₹54.1 Lakh (FY 2025) | Active |
Board colleagues of Ananthaneni Pavana Sudha
| Name | DIN | Company | Designation |
|---|---|---|---|
| Venkatasesha Pavan Swaroop Ananthaneni | 08798236 | Rbc Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ananthaneni Pavana Sudha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ananthaneni Pavana Sudha
Ananthaneni Pavana Sudha currently holds 1 directorship: Rbc Pharmaceuticals Private Limited (Director, since 25 May 2023, revenue ₹54.1 Lakh (FY 2025)).
Ananthaneni Pavana Sudha was first appointed on 25 May 2023 as Director at Rbc Pharmaceuticals Private Limited.
The current boards of Ananthaneni Pavana Sudha's companies include Venkatasesha Pavan Swaroop Ananthaneni (Rbc Pharmaceuticals Private Limited).